United States Blood Glucose Monitoring Devices Market to Grow at a Significant Rate through 2026
Favourable reimbursement policies and
high healthcare expenditure is expected to drive the United States blood
glucose monitoring devices market for the forecast period.
According to TechSci Research report, “United
States Blood Glucose Monitoring Devices Market By Product Type (Self Blood
Glucose Monitoring Devices v/s Continuous Glucose Monitoring Devices) By
Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) By End
User (Home Care Settings, Hospital, Others) By Company, By Region, Forecast &
Opportunities, 2026”, The United States blood glucose monitoring devices
market is expected to witness significant growth for the next five years.
Diabetes is a clinical condition in which the patient has higher level of
glucose in the body due to inability of pancreas to produce insulin. Blood
glucose monitoring devices are necessary for proper diagnosis and treatment as these
devices measure the glucose level in the body. Excess of sugar in human body is
called hyperglycemia and it can cause damage the vessels which supply the blood
to various part of body can increase the risk of stroke and heart disease,
vision and nerve problems and kidney diseases. Hypoglycemia is a condition in
which the glucose level is lower than the normal level and it cause problems
within central nervous systems. Blood glucose monitoring devices can help
preventing these conditions and aids in taking necessary steps for maintaining
the health condition of patients. Patients can measure the glucose levels in
the comfort of their homes with the help of self blood glucose monitoring
devices and check the effects of the treatment of diabetes and plan accordingly
the diet, exercise stress management without facing any hassle. Also, the increasing
United States government initiatives to increase the awareness among consumers
the benefits of diabetes preventive care are boosting the blood glucose
monitoring devices market growth.
The COVID-19 outbreak across the world which has
been declared as pandemic by World Health Organization has affected countries
adversely. Leading authorities in United States imposed lockdown restrictions
and released a set of precautionary measures to contain the spread of novel
coronavirus. Coronavirus affected patients started suffering from shortness of
breath along with coughing and sneezing. United States authorities increased
the capacity of hospitals as a greater number of patients were getting affected
daily and getting admitted into the hospital facilities. Lockdown restrictions
impacted the daily routine of diabetic patients such as eating patterns,
physical conditions and patients indulged in adoption of sedentary lifestyle.
These factors caused fluctuations in blood glucose level of patients which
surged the demand for blood glucose monitoring devices.
Browse XX Figures spread through XX Pages and an in-depth
TOC on "United States Blood
Glucose Monitoring Devices Market”.
https://www.techsciresearch.com/report/united-states-blood-glucose-monitoring-devices-market/7489.html
United States blood glucose monitoring devices market is
segmented into product type, application, end user, regional distribution, and
company. Based on product type, market is further divided into self blood
glucose monitoring devices and continuous glucose monitoring devices. The self
blood glucose motoring devices segment is expected to dominate the market for
the forecast period, 2022-2026. People measure their blood glucose levels with
the help of self blood monitoring devices. This market is again fragmented into
testing strips, lancets, and blood glucose meter. The testing strips segment is
expected to maintain the significant share for the predicted period due to its
cost-effectiveness and easy procedure for testing of blood glucose level in
patient body.
Abbott Laboratories, Inc., Roche Diagnostics Corporation,
Johnson & Johnson, Medtronic USA Inc., Becton, Dickinson, and Company, B.
Braun Medical Inc., Nipro Medical Corporation, Dexcom, Inc., Sanofi-Aventis
U.S. LLC, Eli Lilly and Company are the leading players operating in United
States blood glucose monitoring devices market. Manufacturers are increasingly
focusing on research and development process to fuel higher growth in the
market. To meet evolving customer demand with respect to better efficiency and
durability, several blood glucose monitoring devices manufacturers are coming
up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7489
Customers can also request for 10% free
customization on this report.
“High
prevalence of diabetes and changing lifestyle of people in United States is a
major driver for the growth of the market. High-end investments by market
players for technological advancements of blood glucose monitoring devices is
contributing significantly to the market growth. Consumer preference towards
wireless blood glucose monitoring devices which can be connected with smart
phones using Wi-Fi protocols adds to the convenience and more user-friendly
interface for consumers is expected to propel the growth of the market until
2026” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“United States
Blood Glucose Monitoring Devices Market By Product Type (Self Blood Glucose Monitoring
Devices v/s Continuous Glucose Monitoring Devices) By Application (Type 1
Diabetes, Type 2 Diabetes, Gestational Diabetes) By End User (Home Care
Settings, Hospital, Others) By Company, By Region, Forecast &
Opportunities, 2026” has evaluated the future growth potential of United
States blood glucose monitoring devices market and provided statistics & information
on market size, shares, structure and future market growth. The report intends
to provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in the
of United States blood glucose monitoring devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/